Avalo Therapeutics, Inc. (AVTX) insider trading

By person

26 insiders · 636 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

ARMISTICE CAPITAL, LLC entity

10% owner

$58.19M (515)

$2.17M (2)

+$56.02M

88,947,543

$1.45B

+368.1%

Sullivan Christopher Ryan

Chief Financial Officer

$21.58K (4)

$3.72M (17) scheduled

−$3.70M

39,900

$651.71K

—

Doyle Mittie

Chief Medical Officer

—

$2.98M (17) scheduled

−$2.98M

51,776

$845.68K

+399.1%

Caissa Capital Management ltd. entity

10% owner

$1.68M (34)

—

+$1.68M

$0.00

−100.0%

VARKI PAUL

Chief Legal Officer

—

$1.51M (5) scheduled

−$1.51M

32,576

$532.08K

+214.0%

COLA MICHAEL F

Chief Executive Officer

$250.00K (1)

—

+$250.00K

175,746

$2.87M

—

Goldman Jonathan

Director

—

$162.94K (2) scheduled

−$162.94K

3,166

$51.71K

—

Harrell James Archie Jr

Chief Commercial Officer

$91.83K (8)

—

+$91.83K

36,766

$600.52K

—

Chan Mitchell

Director

—

$72.46K (1) scheduled

−$72.46K

3,166

$51.71K

—

Riley Jennifer

Chief Strategy Officer

—

$52.01K (1)

−$52.01K

37,041

$605.01K

+451.1%

Pedder Simon

Executive Chairman of the Bd

$50.44K (2)

—

+$50.44K

241,833

$3.95M

—

NEIL GARRY ARTHUR

Chief Executive Officer

$50.30K (6)

—

+$50.30K

190,314

$3.11M

—

Greenleaf Peter

Director

$49.75K (1)

—

+$49.75K

112,500

$1.84M

—

Calias Pericles

Chief Scientific Officer

$21.25K (2)

—

+$21.25K

52,462

$856.89K

+1,516%

Hacksell Uli

Director

$14.90K (2)

—

+$14.90K

20,000

$326.67K

—

Almenoff June Sherie

Director

$12.75K (2)

—

+$12.75K

4,167

$68.06K

—

Wilkins H Jeffrey

Chief Medical Officer

$12.08K (2)

—

+$12.08K

33,373

$545.10K

+27.9%

Miller Joseph M

Director

$10.76K (2)

—

+$10.76K

40,582

$662.85K

—

Greenway Schond L.

CFO

$5.25K (2)

—

+$5.25K

3,883

$63.42K

+288.3%

Jones Randal

Director

—

$5.05K (1) scheduled

−$5.05K

2,592,458

$42.34M

0.0%

Phillips Matthew V

Chief Commercial Officer

$2.90K (2)

—

+$2.90K

513,520

$8.39M

—

Moscato Robert Jr.

Director

$504.45 (1)

—

+$504.45

2,592,743

$42.35M

0.0%

Crutcher Patrick J

VP, Business Development

—

1,634,771

$26.70M

—

KAPLAN GILLA

Director

—

6,333

$103.44K

—

Truex Samantha

Director

—

6,333

$103.44K

—

KANTOFF AARON

Director

—

6,333

$103.44K

—

No percentages here. This company's share count has moved by a factor of 5.2 over the window, from 10,393,954 to 53,629,989 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Avalo Therapeutics, Inc.

By person

Individual transactions

What was left out